Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ISTREET NETWORK vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ISTREET NETWORK GLENMARK PHARMA ISTREET NETWORK/
GLENMARK PHARMA
 
P/E (TTM) x -47.3 -41.9 - View Chart
P/BV x - 5.3 - View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ISTREET NETWORK   GLENMARK PHARMA
EQUITY SHARE DATA
    ISTREET NETWORK
Mar-24
GLENMARK PHARMA
Mar-24
ISTREET NETWORK/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs3974 0.3%   
Low Rs1464 0.3%   
Sales per share (Unadj.) Rs0418.6 0.0%  
Earnings per share (Unadj.) Rs-0.1-64.9 0.1%  
Cash flow per share (Unadj.) Rs-0.1-44.3 0.1%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.3 0.0%  
Book value per share (Unadj.) Rs-0.8277.5 -0.3%  
Shares outstanding (eoy) m21.30282.19 7.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x01.7-  
Avg P/E ratio x-38.2-11.1 344.1%  
P/CF ratio (eoy) x-38.2-16.3 234.8%  
Price / Book Value ratio x-2.82.6 -107.8%  
Dividend payout %0-3.9 0.0%   
Avg Mkt Cap Rs m49202,964 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m028,681 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m0118,131 0.0%  
Other income Rs m08,400 0.0%   
Total revenues Rs m0126,531 0.0%   
Gross profit Rs m-12,944 -0.0%  
Depreciation Rs m05,819 0.0%   
Interest Rs m05,160 0.0%   
Profit before tax Rs m-1365 -0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m018,673 0.0%   
Profit after tax Rs m-1-18,309 0.0%  
Gross profit margin %02.5- 
Effective tax rate %05,116.7 -0.0%   
Net profit margin %0-15.5- 
BALANCE SHEET DATA
Current assets Rs m174,281 0.0%   
Current liabilities Rs m258,186 0.0%   
Net working cap to sales %013.6- 
Current ratio x0.71.3 57.4%  
Inventory Days Days031- 
Debtors Days Days057- 
Net fixed assets Rs m158,808 0.0%   
Share capital Rs m85282 30.2%   
"Free" reserves Rs m-10378,015 -0.1%   
Net worth Rs m-1878,297 -0.0%   
Long term debt Rs m180-   
Total assets Rs m2133,089 0.0%  
Interest coverage x01.1-  
Debt to equity ratio x-1.00-  
Sales to assets ratio x00.9 0.0%   
Return on assets %-59.8-9.9 605.4%  
Return on equity %7.3-23.4 -31.3%  
Return on capital %-358.97.1 -5,086.3%  
Exports to sales %00-  
Imports to sales %00-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m032,207 0.0%   
Fx outflow Rs m019,636 0.0%   
Net fx Rs m012,571 0.0%   
CASH FLOW
From Operations Rs m-1-2,654 0.0%  
From Investments Rs mNA45,609 0.0%  
From Financial Activity Rs mNA-39,061 -0.0%  
Net Cashflow Rs m-12,152 -0.0%  

Share Holding

Indian Promoters % 46.2 46.7 99.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 36.3 -  
FIIs % 0.0 23.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 53.8 53.4 100.8%  
Shareholders   11,450 193,949 5.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ISTREET NETWORK With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on PRINCIPAL PHARMA vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PRINCIPAL PHARMA vs Glenmark Pharma Share Price Performance

Period PRINCIPAL PHARMA Glenmark Pharma S&P BSE HEALTHCARE
1-Day -4.76% 0.68% 0.96%
1-Month -11.76% -12.35% -0.51%
1-Year 24.48% 90.00% 43.24%
3-Year CAGR 8.33% 46.51% 20.24%
5-Year CAGR 8.02% 33.82% 26.18%

* Compound Annual Growth Rate

Here are more details on the PRINCIPAL PHARMA share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of PRINCIPAL PHARMA hold a 46.2% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PRINCIPAL PHARMA and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, PRINCIPAL PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at -3.9%.

You may visit here to review the dividend history of PRINCIPAL PHARMA, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.